The objective of the present study was to incorporate strontium into calcium phosphate cement combined with a lower single-dose local administration of bone morphogenetic protein-2 to enhance its in vivo biodegradation and bone tissue growth. After the creation of a rodent critical-sized femoral metaphyseal bone defect, strontium-modified calcium phosphate cement was prepared by mixing sieved granules of calcium phosphate cement and 5% SrCO3 for medical use, and then strontium-modified calcium phosphate cement with dripped bone morphogenetic protein-2 solution (5 µg) was implanted into the defect of OVX rats until death at eight weeks. The defected area in distal femurs of rats was harvested for evaluation by histology, micro-CT, and biomechanics. The results of our study show that a lower single-dose local administration of bone morphogenetic protein-2 combined local usage of strontium-modified calcium phosphate cement can increase the healing of defects in OVX rats. Furthermore, treatments with single-dose local administration of bone morphogenetic protein-2 and strontium-modified calcium phosphate cement showed a stronger effect on accelerating the local bone formation than calcium phosphate cement and strontium-modified calcium phosphate cement used alone. The results from our study demonstrate that combination of a lower single-dose local administration of bone morphogenetic protein-2 and strontium-modified calcium phosphate cement had an additive effect on local bone formation in osteoporosis rats.
StrömOBorgströmFKanisJAet al.
Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos2011;
6: 59–155.
2.
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA2001; 285: 785–795.
3.
KanisJABurletNCooperCet al.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int2008;
19: 399–428.
4.
HernándezASánchezESorianoIet al.
Material-related effects of BMP-2 delivery systems on bone regeneration. Acta Biomater2012;
8: 781–791.
5.
ThormannURaySSommerUet al.
Bone formation induced by strontium modified calcium phosphate cement in critical-size metaphyseal fracture defects in ovariectomized rats. Biomaterials2013;
34: 8589–8598.
6.
WangZWangKLuXet al.
BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration. J Biomed Mater Res A2015;
103: 1520–1532.
7.
HuangBTianYZhangWet al.
Strontium doping promotes bioactivity of rhBMP-2 upon calcium phosphate cement via elevated recognition and expression of BMPR-IA. Colloids Surf B Biointerf2017;
159: 684
8.
ReedS andWuB.Sustained growth factor delivery in tissue engineering applications. Ann Biomed Eng2014;
42: 1528–1536.
9.
TaoZSZhouWSHeXWet al.
A comparative study of zinc, magnesium, strontium-incorporated hydroxyapatite-coated titanium implants for osseointegration of osteopenic rats. Mater Sci Eng C Mater Biol Appl2016;
62: 226–232.
10.
GengZWangRZhuoXet al.
Incorporation of silver and strontium in hydroxyapatite coating on titanium surface for enhanced antibacterial and biological properties. Mater Sci Eng C Mater Biol Appl2017;
71: 852–861.
11.
TaoZSBaiBLHeXWet al.
A comparative study of strontium-substituted hydroxyapatite coating on implant's osseointegration for osteopenic rats. Med Biol Eng Comput2016;
54: 1959–1968.
12.
BoseSTarafderSBanerjeeSSet al.
Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped β-TCP. Bone2011;
48: 1282
13.
KisslingSSeidenstueckerMPilzIHet al.
Sustained release of rhBMP-2 from microporous tricalciumphosphate using hydrogels as a carrier. BMC Biotechnol2016;
16: 44
14.
PolakSJLevengoodSKLWheelerMBet al.
Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds. Acta Biomater2011;
7: 1760–1771.
15.
AgrawalV andSinhaM.A review on carrier systems for bone morphogenetic protein-2. J Biomed Mater Res Part B Appl Biomater2016;
105: 904–925.
16.
ZhaoLWangHHuoKet al.
The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials2013;
34: 19–29.
17.
JiangFWangDPYeSet al.
Strontium-substituted, luminescent and mesoporous hydroxyapatite microspheres for sustained drug release. J Mater Sci Mater Med2014;
25: 391–400.
18.
TaoZSBaiBLHeXWet al. A comparative study of strontium-substituted hydroxyapatite coating on implant's osseointegration for osteopenic rats. Med Biol Eng Comput2016; 54: 1959–1968.
19.
TaoZSZhouWSTuKKet al.
Treatment study of distal femur for parathyroid hormone (1-34) and beta-tricalcium phosphate on bone formation in critical-sized defects in osteopenic rats. J Cranio Maxillo Facial Surg2015;
43: 2136–2143.
20.
ZhangYChengNMironRet al.
Delivery of PDGF-B and BMP-7 by mesoporous bioglass/silk fibrin scaffolds for the repair of osteoporotic defects. Biomaterials2012;
33: 6698–6708.
21.
ZhangYWuCLuoTet al.
Synthesis and inflammatory response of a novel silk fibroin scaffold containing BMP7 adenovirus for bone regeneration. Bone2012;
51: 704–713.
22.
TaoZSZhouWSBaiBLet al.
The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs. J Mater Sci Mater Med2016;
27: 43.
23.
YangNCuiYTanJet al.
Local injection of a single dose of simvastatin augments osteoporotic bone mass in ovariectomized rats. J Bone Miner Metab2014;
32: 252–260.
24.
TaoZSQiangZTuKKet al.
Treatment study of distal femur for parathyroid hormone (1-34) and beta-tricalcium phosphate on bone formation in critical size defects in rats. J Biomater Appl2015;
30: 484–491.
25.
TaoZSZhouWSWuXJet al. Single-dose local administration of parathyroid hormone (1-34, PTH) with beta-tricalcium phosphate/collagen (beta-TCP/COL) enhances bone defect healing in ovariectomized rats. J Bone Miner Metab. Epub ahead of print 1 February 2018. DOI: 10.1007/s00774-018-0906-3.
26.
TaoZSZhouWSTuKKet al.
Effect exerted by Teriparatide upon Repair Function of beta-tricalcium phosphate to ovariectomised rat's femoral metaphysis defect caused by osteoporosis. Injury2015;
46: 2134–2141.
27.
QiS.Synergistic effects of genistein and zinc on bone metabolism and the femoral metaphyseal histomorphology in the ovariectomized rats. Biol Trace Element Res2017;
37: 362
28.
LiuYWuG andGrootKD.Biomimetic coatings for bone tissue engineering of critical-sized defects.J R Soc Interface2010;
7(Suppl. 5): S631–S647
29.
TaoZSTuKKHuangZLet al.
Combined treatment with parathyroid hormone (1-34) and beta-tricalcium phosphate had an additive effect on local bone formation in a rat defect model. Med Biol Eng Comput2016;
54: 1353–1362.
30.
TaoZSLvYXCuiWet al.
Effect of teriparatide on repair of femoral metaphyseal defect in ovariectomized rats. Z Gerontol Geriatr2016;
49: 423–428.
31.
BuenoEM andGlowackiJ.Cell-free and cell-based approaches for bone regeneration. Nat Rev Rheumatol2009;
5: 685–697.
32.
WuYHouJYinMet al.
Enhanced healing of rabbit segmental radius defects with surface-coated calcium phosphate cement/bone morphogenetic protein-2 scaffolds. Mater Sci Eng C Mater Biol Appl2014;
44: 326–335.
33.
BonnelyeEChabadelASaltelFet al.
Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone2008;
42: 129
34.
GaoCLiuHLuoZPet al.
Modification of calcium phosphate cement with poly (γ-glutamic acid) and its strontium salt for kyphoplasty application. Mater Sci EngC Mater Biol Appl2017;
80: 352
35.
LodeAHeissCKnappGet al.
Strontium-modified premixed calcium phosphate cements for the therapy of osteoporotic bone defects. Acta Biomater2018;
65: 475
36.
VavkenJMameghaniAVavkenPet al.
Complications and cancer rates in spine fusion with recombinant human bone morphogenetic protein-2 (rhBMP-2). Eur Spine J2016;
25: 3979–3989.
